» Articles » PMID: 39479675

The Effect of Astaxanthin After Varicocele Surgery on Antioxidant Status and Semen Quality in Infertile Men: A Triple-blind Randomized Clinical Trial

Overview
Journal Food Sci Nutr
Specialty Biotechnology
Date 2024 Oct 31
PMID 39479675
Authors
Affiliations
Soon will be listed here.
Abstract

Varicocele (VC) is widely recognized as a prevalent etiological factor contributing to male infertility. It has been established that the generation of reactive oxygen species (ROS) plays a significant role in the progression and development of VC. Antioxidants may regulate ROS levels in these patients. Astaxanthin (ASX) is a carotenoid compound with notable antioxidant and anti-inflammatory characteristics. The current study postulated that the administration of ASX following varicocelectomy (VCT) could potentially enhance antioxidant status and semen quality in these patients. A total of 40 infertile males with clinical VC and abnormal semen analyses were randomly assigned to take part in the current trial. For 3 months following surgery, the intervention group took ASX (6 mg/day) while the control group received a placebo. After intervention, semen parameters, status, pro-inflammatory cytokines were compared between the two groups. Regarding semen parameters, antioxidant treatment led to a significant improvement in total and progressive motility in the treatment group ( < 0.05). Additionally, ASX led to a considerable increase in the expression levels of NRF2, Keap1, SOD2, SOD3, and BCL2, though the enhancement in the expression level of SOD3 was not statistically significant ( > .05). However, ASX significantly decreased the BAX expression level ( < .05). Even though the level of total antioxidant capacity (TAC) of seminal fluid (SF) increased significantly in the treatment group ( < .05), the level of total oxidative stress (TOS) in SF did not differ substantially between treatment and control groups ( > .05). Based on inflammatory factors in SF, ASX led to a considerable reduction in levels of TNF-α, IL-1β, and IL-6 ( < .05). Our findings demonstrated that ASX treatment provides an important contribution to VCT outcomes by modulating antioxidant status and pro-inflammatory cytokines. Our results indicated that ASX may be beneficial as an adjuvant therapy for infertile men following VCT.

References
1.
Pereira C, Souza A, Vasconcelos A, Prado P, Name J . Antioxidant and anti‑inflammatory mechanisms of action of astaxanthin in cardiovascular diseases (Review). Int J Mol Med. 2020; 47(1):37-48. PMC: 7723678. DOI: 10.3892/ijmm.2020.4783. View

2.
Fu J, Sun H, Wei H, Dong M, Zhang Y, Xu W . Astaxanthin alleviates spinal cord ischemia-reperfusion injury via activation of PI3K/Akt/GSK-3β pathway in rats. J Orthop Surg Res. 2020; 15(1):275. PMC: 7376638. DOI: 10.1186/s13018-020-01790-8. View

3.
Moretti E, Collodel G, Mazzi L, Campagna M, Iacoponi F, Figura N . Resistin, interleukin-6, tumor necrosis factor-alpha, and human semen parameters in the presence of leukocytospermia, smoking habit, and varicocele. Fertil Steril. 2014; 102(2):354-60. DOI: 10.1016/j.fertnstert.2014.04.017. View

4.
Lu J, Huang Y, Lu N . [WHO Laboratory Manual for the Examination and Processing of Human Semen: its applicability to andrology laboratories in China]. Zhonghua Nan Ke Xue. 2011; 16(10):867-71. View

5.
Niture S, Jaiswal A . Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis. J Biol Chem. 2012; 287(13):9873-9886. PMC: 3323009. DOI: 10.1074/jbc.M111.312694. View